BofA warns Fed risks policy mistake with early rate cuts
Investing.com - RBC Capital has raised its price target on The Pennant Group (NASDAQ:PNTG) to $34.00 from $33.00 while maintaining an Outperform rating on the healthcare services company. The new target represents significant upside potential from the current stock price of $25.07, with InvestingPro analysis suggesting the stock is currently undervalued.
The price target increase follows The Pennant Group’s second-quarter 2025 financial results, which RBC Capital noted were in line with its expectations.
According to RBC Capital, the company’s quarterly performance was driven by "broad-based topline strength and solid cost controls," leading to adjusted EBITDA results that met analyst projections.
The new $34 price target reflects a target enterprise multiple of 11.6 times RBC Capital’s 2026 adjusted EBITDAR estimate for The Pennant Group.
RBC Capital initially published a Quick Take note on The Pennant Group’s results on August 6, with Wednesday’s update providing additional commentary and model adjustments based on the quarterly performance.
In other recent news, Pennant Group Inc . reported its second-quarter earnings for 2025, revealing a strong financial performance. The company achieved revenue of $219.5 million, which exceeded the forecasted $210.59 million. Earnings per share (EPS) aligned with expectations, coming in at $0.27. This performance reflects the company’s ability to meet analyst projections, contributing to investor confidence. These developments are part of a series of recent updates concerning the company. While earnings and revenue figures are critical for investors, no additional information about mergers or analyst upgrades and downgrades was provided in the recent updates. The company’s financial results continue to be a focal point for stakeholders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.